Celldex Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $16M | 409k | 39.66 |
| 2023-09-30 | $9.9M | 362k | 27.52 |
| 2023-06-30 | $12M | 351k | 33.93 |
| 2023-03-31 | $13M | 347k | 35.98 |
| 2022-12-31 | $16M | 348k | 44.57 |
| 2022-09-30 | $9.5M | 338k | 28.11 |
| 2022-06-30 | $8.9M | 331k | 26.96 |
| 2022-03-31 | $12M | 337k | 34.06 |
| 2021-12-31 | $13M | 328k | 38.64 |
| 2021-09-30 | $17M | 323k | 53.99 |
| 2021-06-30 | $3.3M | 98k | 33.44 |
| 2021-03-31 | $299k | 15k | 20.61 |
| 2020-12-31 | $255k | 15k | 17.58 |
| 2020-09-30 | $246k | 17k | 14.84 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management